Research Analysts’ Recent Ratings Changes for UiPath (PATH)

A number of research firms have changed their ratings and price targets for UiPath (NYSE: PATH):

• 12/30/2025 – UiPath was upgraded by analysts at Zacks Research from a “hold” rating to a “strong-buy” rating.
• 12/29/2025 – UiPath had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – UiPath had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 12/15/2025 – UiPath had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 12/10/2025 – UiPath had its price target raised by analysts at Royal Bank Of Canada from $16.00 to $19.00. They now have a “sector perform” rating on the stock.
• 12/9/2025 – UiPath was upgraded by analysts at Weiss Ratings from a “sell (d+)” rating to a “hold (c)” rating.
• 12/9/2025 – UiPath had its price target raised by analysts at Morgan Stanley from $15.00 to $19.00. They now have an “equal weight” rating on the stock.
• 12/6/2025 – UiPath was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating.
• 12/4/2025 – UiPath was given a new $17.00 price target on by analysts at Truist Financial Corporation.
• 12/4/2025 – UiPath had its price target raised by analysts at BMO Capital Markets from $13.00 to $17.00. They now have a “market perform” rating on the stock.
• 12/4/2025 – UiPath had its “neutral” rating reaffirmed by analysts at UBS Group AG.
• 12/4/2025 – UiPath had its price target raised by analysts at Royal Bank Of Canada from $14.00 to $16.00. They now have a “sector perform” rating on the stock.
• 12/4/2025 – UiPath had its “hold” rating reaffirmed by analysts at Cowen Inc.
• 12/4/2025 – UiPath had its price target raised by analysts at DA Davidson from $12.00 to $15.00. They now have a “neutral” rating on the stock.
• 12/4/2025 – UiPath had its price target raised by analysts at Evercore ISI from $15.00 to $17.00. They now have an “in-line” rating on the stock.
• 12/4/2025 – UiPath had its price target raised by analysts at Mizuho from $14.00 to $15.00. They now have a “neutral” rating on the stock.
• 12/4/2025 – UiPath had its price target raised by analysts at Canaccord Genuity Group Inc. from $15.00 to $19.00. They now have a “buy” rating on the stock.
• 12/4/2025 – UiPath had its price target raised by analysts at Barclays PLC from $14.00 to $16.00. They now have an “equal weight” rating on the stock.
• 12/4/2025 – UiPath had its price target raised by analysts at Wells Fargo & Company from $12.00 to $14.00. They now have an “equal weight” rating on the stock.
• 12/4/2025 – UiPath had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
• 11/15/2025 – UiPath was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating.
• 11/4/2025 – UiPath was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.

Insider Activity at UiPath

In other UiPath news, insider Brad Brubaker sold 66,665 shares of UiPath stock in a transaction on Monday, October 6th. The shares were sold at an average price of $15.00, for a total value of $999,975.00. Following the transaction, the insider directly owned 690,519 shares of the company’s stock, valued at approximately $10,357,785. The trade was a 8.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Daniel Dines sold 122,734 shares of the business’s stock in a transaction on Monday, October 13th. The stock was sold at an average price of $17.06, for a total value of $2,093,842.04. Following the transaction, the chief executive officer owned 368,202 shares in the company, valued at approximately $6,281,526.12. This trade represents a 25.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 1,966,368 shares of company stock valued at $32,488,123 over the last ninety days. 23.19% of the stock is owned by company insiders.

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.